BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25564959)

  • 21. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of IL-10 and IL-6 Gene Polymorphisms and Their Serum Levels in Patients with Brucellosis: A Case Control Study.
    Kazemi S; Saidijam M; Hashemi SH; Karami M; Vaisi-Raygani A; Alikhani MY
    Immunol Invest; 2016; 45(2):107-15. PubMed ID: 26849072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of interleukin-6 and C-reactive protein genetic polymorphisms levels with venous thromboembolism.
    Mahemuti A; Abudureheman K; Aihemaiti X; Hu XM; Xia YN; Tang BP; Upur H
    Chin Med J (Engl); 2012 Nov; 125(22):3997-4002. PubMed ID: 23158132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H2AFX polymorphisms are associated with decreased risk of diffuse large B cell lymphoma in Koreans.
    Jin XM; Kim HN; Shin MH; Lee IK; Lee JS; Lee JH; Kim HJ; Choi JS; Juhng SW; Choi C
    DNA Cell Biol; 2011 Dec; 30(12):1039-44. PubMed ID: 21631283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population.
    Talaat RM; Dondeti MF; El-Shenawy SZ; Khamiss OA
    Biochem Genet; 2014 Oct; 52(9-10):387-402. PubMed ID: 24838671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of interleukin (IL)-6 gene polymorphisms on recurrent aphthous stomatitis.
    Karakus N; Yigit S; Rustemoglu A; Kalkan G; Bozkurt N
    Arch Dermatol Res; 2014 Mar; 306(2):173-80. PubMed ID: 23982631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-12B gene polymorphism frequencies in Egyptians and sex-related susceptibility to hepatitis C infection.
    Youssef SS; Mostafa A; Nasr AS; el Zanaty T; Seif SM
    J Interferon Cytokine Res; 2013 Aug; 33(8):415-9. PubMed ID: 23600862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
    Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
    J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variations in tumor ecrosis factor related apoptosis-inducing ligand receptor-1 (TRAIL-R1) gene and the susceptibility to b-cell non-hodgkin lymphoma (B-NHL) in Egypt.
    Khorshied M; Soliman N; Khorshid O; Bakr S
    Cancer Biomark; 2021; 32(4):451-458. PubMed ID: 34275891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
    Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
    J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
    Cao C; Liu S; Lou SF; Liu T
    Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interleukin-6-597G/A and -572C/G polymorphisms and risk of coronary heart disease].
    Fu HX; Li GS; Li Y; Xu JL; Zhang JY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):519-22. PubMed ID: 16842669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of MNS16A VNTR and hTERT rs2736098: G>A polymorphisms with susceptibility to diffuse large B-cell lymphoma.
    Essa ES; Alagizy HA
    Tumori; 2018 Jun; 104(3):165-171. PubMed ID: 28967095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
    Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
    Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 promotor gene polymorphisms and susceptibility to chronic hepatitis B virus in Egyptians.
    El-Maadawy EA; Talaat RM; Ahmed MM; El-Shenawy SZ
    Hum Immunol; 2019 Mar; 80(3):208-214. PubMed ID: 30594561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma.
    Kim HN; Yu L; Kim NY; Lee IK; Kim YK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
    Am J Hematol; 2010 Oct; 85(10):822-4. PubMed ID: 20734458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma.
    Makhlouf MM; Radwan ER; Khorshed OM; Fathi LM; Elmasry MM
    Pathobiology; 2021; 88(3):211-217. PubMed ID: 33378752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
    Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial.
    Schoof N; von Bonin F; Zeynalova S; Ziepert M; Jung W; Loeffler M; Pfreundschuh M; Trümper L; Kube D
    Ann Oncol; 2009 Sep; 20(9):1548-1554. PubMed ID: 19515749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.